Our Partners & Affiliates
We work closely with our HEI partners and clinical teams across Wales to bring a unique collaboration between Swansea University and University of Wales, Trinity Saint David.
University of Wales Trinity Saint David and ATiC
The Assistive Technologies Innovation Centre (ATiC) at the University of Wales Trinity Saint David (UWTSD) is dedicated to transforming lives through research and innovation in healthcare. ATiC collaborates with academic, public, private, and third sector partners from the life sciences, health, and social care sectors to foster a culture of research excellence, knowledge transfer, and innovation in health and wellbeing.
ATiC employs user-centred design research methods and objective physiological measurement tools to understand people’s needs and performance during their interaction with healthcare products, services, systems, and spaces. This approach helps partners develop innovative solutions that improve health and wellbeing. The centre is equipped with state-of-the-art facilities, including a multimodal User Experience (UX) and Usability Evaluation (UE) laboratory, 3D scanning, modelling, virtual simulation, additive manufacturing, and prototyping capabilities. These resources support the rapid development and evaluation of new health technologies.
Overall, ATiC is a key contributor to the health innovation ecosystem in Wales, driving positive economic impact through co-design practices and collaboration with various partners
Swansea University and The Healthcare Technology Centre
The Faculty of Medicine, Health and Life Science at Swansea University is dedicated to making a significant impact on people’s lives through interdisciplinary and interprofessional learning, research, and innovation. The faculty is consistently rated as a top UK provider of health professional and life sciences education, maintaining an international reputation for excellent research and innovation.The faculty’s research focuses on improving health, wellbeing, and wealth, with a strong emphasis on real-world impact and better patient outcomes. Their research environment is highly regarded, with 85% of their research rated as world-leading or internationally excellent. The Institute of Life Science (ILS) is a key component of the faculty, housing state-of-the-art research laboratories, business incubation facilities, and advanced clinical research facilities. The ILS supports innovative medical treatments and the advancement of healthcare through the application of nanotechnology and other cutting-edge technologies.
Swansea University’s Faculty of Medicine, Health and Life Science is a leader in health and life sciences education and research, driving forward improvements in health and wellbeing both locally and globally.
Affiliates
Collaborations
We partner with industry-leading affiliates to provide support through a multidisciplinary approach. This includes translating innovations into real-world clinical settings to help our communities lead healthier lives. These partnerships highlight our commitment to leveraging research, clinical expertise, and innovation to enhance healthcare services and patient care.
Cardiovascular Health:
We have partnered with AMGEN:
The Tritech Institute, in collaboration with Swansea Bay University Health Board, Swansea University, and global biotechnology firm Amgen, is working on the “Next Generation Population Health in NHS Wales” project. This initiative focuses on improving the diagnosis and treatment of cardiovascular patients across Wales. The project aims to develop a Learning Laboratory for population risk prediction and evaluate the effectiveness of high-intensity specialised clinics.
Respiratory Health:
We have partnered with Astra Zeneca:
AstraZeneca’s Interface Asthma Network Service is part of their broader commitment to improving asthma care globally. This service focuses on optimizing asthma management by integrating advanced digital tools and fostering collaboration among healthcare providers. The initiative aims to reduce asthma attacks, enhance patient outcomes, and minimize the environmental impact of asthma care.
We have partnered with all health boards across Wales and the Institute of Clinical Science and Technology:
Our partnership with all health boards across Wales to facilitate a real world evaluation of the Institute of Clinical Science and Technology’s digital respiratory toolkit is making a significant progress. The toolkit, which has been widely adopted, provides digital support for both patients and practitioners, promoting better management of respiratory conditions.
Prostate Cancer:
We have partnered with Cancer Research UK.
A Novel Prostate Cancer Diagnostic Pathway, funded by Cancer Research UK’s ‘Test, Evidence and Transition Programme’ (TETP), is poised to significantly impact prostate cancer diagnosis and treatment. This initiative aims to streamline the diagnostic process, reducing delays that often lead to poorer outcomes. By incorporating advanced techniques such as multi-parametric MRI and Local Anaesthetic Transperineal Biopsies, the pathway promises more accurate and timely diagnoses. This project not only enhances patient care but also sets a precedent for innovation in healthcare delivery, potentially serving as a model for other diagnostic pathways.
We have partnered with JIVA.AI and Moondance Cancer
A collaboration between Hywel Dda University Health Board (HDdUHB), JIVA.AI and Moondance Cancer Initiative ltd. JivaRDX is a radiology-facing application that graphically outlines tumour presence from prostate MRI scans. Operationally, JivaRDX slots into the radiology workflow non-disruptively by automatically annotating DICOM files directly. JivaRDX will reduce overdiagnosis and minimise the human and financial burden on healthcare systems. JivaRDX will increase diagnostic accuracy, increase speed to decision and empower clinicians to gain more insightful diagnoses. It will mean that patients have faster diagnostic and commencement of treatment.
Horizon Europe:
The Tritech Institute, in collaboration with partners across Europe, is working on:
Horizon Europe DYNAMO – the project focuses on enhancing the resilience of critical sectors like energy, health, and transport against cyber threats. By integrating business continuity management (BCM) and cyber threat intelligence (CTI), DYNAMO aims to develop a comprehensive platform that supports situational awareness and decision-making across all stages of the resilience cycle. This project involves 15 partners from ten countries, working together to create tools that help organizations recover quickly from cyberattacks and maintain essential services.
Invest4Health, another Horizon Europe initiative, seeks to transform public health financing by promoting innovative investment models for health promotion and disease prevention. The project addresses the need for sustainable funding in these areas, aiming to shift the focus from reactive to preventative healthcare. By developing and testing new financing methods, Invest4Health aims to ensure that effective health interventions are delivered to the right populations at the right time, ultimately improving health outcomes and reducing the burden on healthcare systems.
